Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Miller

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Utility of fine-needle aspiration as a diagnostic technique in lymphomaSean T Hehn, Thomas M Grogan, Thomas P Miller
Bioinformatics (Oxford, England)|April 15, 2003
Directed indices for exploring gene expression dataMichael LeBlanc, Charles Kooperberg, Thomas M Grogan, et al.
American Journal of Clinical Oncology|February 2, 2002
External beam radiation therapy in the treatment of patients with extranodal stage IA non-Hodgkin's lymphomaJonathan H Briggs, Ozer Algan, Thomas P Miller, et al.
Case Reports in Oncological Medicine|November 7, 2013
Heart of lymphoma: primary mediastinal large B-cell lymphoma with endomyocardial involvementElisa Rogowitz, Hani M Babiker, Ravitharan Krishnadasan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology GroupSteven H Bernstein, Joseph M Unger, Michael Leblanc, et al.
International Journal of Cancer|July 29, 2011
AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomasWenqing Qi, Xiaobing Liu, Laurence S Cooke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
New treatment options have changed the survival of patients with follicular lymphomaRichard I Fisher, Michael LeBlanc, Oliver W Press, et al.
The Journal of Biological Chemistry|November 10, 2005
Chemical blockage of the proteasome inhibitory function of bortezomib: impact on tumor cell deathYolanda Fernández, Thomas P Miller, Christophe Denoyelle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911Oliver W Press, Joseph M Unger, Rita M Braziel, et al.
Molecular Cancer Therapeutics|December 24, 2005
Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signaturesDaruka Mahadevan, Catherine Spier, Kimiko Della Croce, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Utility of fine-needle aspiration as a diagnostic technique in lymphomaSean T Hehn, Thomas M Grogan, Thomas P Miller
Bioinformatics (Oxford, England)|April 15, 2003
Directed indices for exploring gene expression dataMichael LeBlanc, Charles Kooperberg, Thomas M Grogan, et al.
American Journal of Clinical Oncology|February 2, 2002
External beam radiation therapy in the treatment of patients with extranodal stage IA non-Hodgkin's lymphomaJonathan H Briggs, Ozer Algan, Thomas P Miller, et al.
Case Reports in Oncological Medicine|November 7, 2013
Heart of lymphoma: primary mediastinal large B-cell lymphoma with endomyocardial involvementElisa Rogowitz, Hani M Babiker, Ravitharan Krishnadasan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology GroupSteven H Bernstein, Joseph M Unger, Michael Leblanc, et al.
International Journal of Cancer|July 29, 2011
AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomasWenqing Qi, Xiaobing Liu, Laurence S Cooke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
New treatment options have changed the survival of patients with follicular lymphomaRichard I Fisher, Michael LeBlanc, Oliver W Press, et al.
The Journal of Biological Chemistry|November 10, 2005
Chemical blockage of the proteasome inhibitory function of bortezomib: impact on tumor cell deathYolanda Fernández, Thomas P Miller, Christophe Denoyelle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911Oliver W Press, Joseph M Unger, Rita M Braziel, et al.
Molecular Cancer Therapeutics|December 24, 2005
Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signaturesDaruka Mahadevan, Catherine Spier, Kimiko Della Croce, et al.
Pageof 7